Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Nov 24, 2025 FORM 4
4 Nov 21, 2025 4
4 Nov 21, 2025 4
4 Nov 21, 2025 4
4 Nov 17, 2025 PRIMARY DOCUMENT
SCHEDULE 13G/A Nov 14, 2025
SCHEDULE 13G/A Nov 14, 2025
10-Q Nov 10, 2025 10-Q
8-K Nov 10, 2025 8-K
4 Nov 7, 2025
144 Nov 7, 2025
4 Oct 22, 2025 FORM 4
4 Oct 22, 2025 FORM 4
4 Oct 22, 2025 FORM 4
4 Oct 17, 2025
144 Oct 17, 2025
144 Oct 16, 2025
144 Oct 15, 2025
4 Oct 14, 2025
144 Oct 14, 2025
144 Oct 9, 2025
4 Oct 8, 2025 FORM 4
144 Oct 8, 2025
144 Oct 7, 2025
144 Oct 6, 2025
← Newer Page 8 of 40 · 999 filings Older →